Sun Pharma Advanced Research Company Limited
NSE:SPARC.NS
219.74 (INR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 755.5 | 2,307.8 | 1,372.489 | 2,529.571 | 768.144 | 1,828.692 | 782.589 | 1,810.248 | 1,612.824 | 1,557.375 | 1,670.297 | 872.79 | 289.765 | 583.478 | 344.068 | 351.419 | 374.629 | 3.101 | 0 |
| Cost of Revenue
| 1,824.8 | 1,715.8 | 1,266.971 | 2,064.017 | 1,932.239 | 1,604.274 | 1,441.689 | 1,710.391 | 1,384.131 | 1,207.095 | 80.079 | 93.054 | 74.155 | 76.823 | 67.627 | 93.777 | 68.618 | 3.101 | 0 |
| Gross Profit
| -1,069.3 | 592 | 105.518 | 465.554 | -1,164.095 | 224.418 | -659.1 | 99.857 | 228.693 | 350.28 | 1,590.218 | 779.736 | 215.61 | 506.655 | 276.441 | 257.642 | 306.011 | 0 | 0 |
| Gross Profit Ratio
| -1.415 | 0.257 | 0.077 | 0.184 | -1.515 | 0.123 | -0.842 | 0.055 | 0.142 | 0.225 | 0.952 | 0.893 | 0.744 | 0.868 | 0.803 | 0.733 | 0.817 | 0 | 0 |
| Reseach & Development Expenses
| 1,013.5 | 4,528.355 | 3,239.983 | 3,879.348 | 3,868.252 | 1,478.987 | 3,208.673 | 3,037.238 | 2,244.756 | 1,908.336 | 1,335.389 | 1,040.445 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,524.6 | 1,319.5 | 695.227 | 519.34 | 439.209 | 560.333 | 484.276 | 47.136 | 35.579 | 23.278 | 533.654 | 418.73 | 472.742 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 538.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2,063.3 | 1,319.5 | 695.227 | 519.34 | 439.209 | 560.333 | 484.276 | 47.136 | 35.579 | 23.278 | 533.654 | 418.73 | 472.742 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 294.7 | 108.8 | 0.771 | 4.711 | 0.31 | 9.309 | 0.117 | -6.628 | 18.737 | -2.275 | -2.183 | -2.784 | 0.004 | 590.372 | 488.379 | 380.128 | 0.649 | 0.041 | 0 |
| Operating Expenses
| 3,076.8 | 2,930.3 | 2,066.245 | 1,924.564 | 1,985.45 | 1,745.593 | 1,848.649 | 1,412.181 | 930.167 | 769.595 | 1,288.056 | 976.59 | 946.387 | 590.372 | 488.379 | 380.128 | 352.275 | 15.283 | 0 |
| Operating Income
| -4,146.1 | -2,149.5 | -1,969.1 | -1,459.01 | -3,149.545 | -1,521.175 | -2,507.749 | -1,312.324 | -701.474 | -419.315 | 302.162 | -196.854 | -730.777 | -83.717 | -211.938 | -122.486 | -46.264 | -18.384 | 0 |
| Operating Income Ratio
| -5.488 | -0.931 | -1.435 | -0.577 | -4.1 | -0.832 | -3.204 | -0.725 | -0.435 | -0.269 | 0.181 | -0.226 | -2.522 | -0.143 | -0.616 | -0.349 | -0.123 | -5.928 | 0 |
| Total Other Income Expenses Net
| 277.8 | -76.3 | -64.9 | -52.378 | 25.511 | 66.867 | 537.77 | 109.651 | 1.554 | 24.115 | 41.08 | -28.093 | 8.456 | -1.28 | -3.5 | -2.427 | 0.649 | 0.041 | 0 |
| Income Before Tax
| -3,868.3 | -2,225.8 | -2,033.954 | -1,511.388 | -3,124.034 | -1,454.308 | -1,969.979 | -1,202.673 | -699.92 | -395.2 | 343.242 | -224.947 | -722.321 | -84.997 | -215.438 | -124.913 | -45.615 | -18.343 | 0 |
| Income Before Tax Ratio
| -5.12 | -0.964 | -1.482 | -0.597 | -4.067 | -0.795 | -2.517 | -0.664 | -0.434 | -0.254 | 0.205 | -0.258 | -2.493 | -0.146 | -0.626 | -0.355 | -0.122 | -5.915 | 0 |
| Income Tax Expense
| 3.8 | 117.472 | 14.816 | 43.822 | -15.739 | -5.606 | 7.695 | 127.974 | 23.843 | 24.299 | 40 | 2.438 | 11.08 | 0.01 | 215.342 | -33.508 | 3.212 | 31.498 | 0 |
| Net Income
| -3,872.1 | -2,225.8 | -2,033.954 | -1,511.388 | -3,124.034 | -1,454.308 | -1,969.979 | -1,202.673 | -699.92 | -395.2 | 303.242 | -224.947 | -722.321 | -85.007 | -215.534 | -91.405 | -48.827 | -49.841 | 0 |
| Net Income Ratio
| -5.125 | -0.964 | -1.482 | -0.597 | -4.067 | -0.795 | -2.517 | -0.664 | -0.434 | -0.254 | 0.182 | -0.258 | -2.493 | -0.146 | -0.626 | -0.26 | -0.13 | -16.073 | 0 |
| EPS
| -11.93 | -7.82 | -7.73 | -5.77 | -11.92 | -5.69 | -7.94 | -4.89 | -2.96 | -1.67 | 1.27 | -1.03 | -3.41 | -0.4 | -1.02 | -0.43 | -0.24 | -0.24 | 0 |
| EPS Diluted
| -11.93 | -7.82 | -7.73 | -5.77 | -11.92 | -5.69 | -7.94 | -4.89 | -2.96 | -1.67 | 1.27 | -1.03 | -3.41 | -0.4 | -1.02 | -0.43 | -0.23 | -0.24 | 0 |
| EBITDA
| -4,021 | -2,031.8 | -1,852.619 | -1,305.955 | -3,070.479 | -1,451.257 | -2,418.208 | -1,101.953 | -601.845 | -322.62 | 388.757 | -160.461 | -688.074 | -53.858 | -185.947 | -104.122 | -33.59 | -17.38 | 0 |
| EBITDA Ratio
| -5.322 | -0.88 | -1.35 | -0.516 | -3.997 | -0.794 | -3.09 | -0.609 | -0.373 | -0.207 | 0.233 | -0.184 | -2.375 | -0.092 | -0.54 | -0.296 | -0.09 | -5.605 | 0 |